| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Nuclear Medicine |
1 All authors: Division of Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 57, Houston, TX 77030.
OBJECTIVE. A potential source of false-positive FDG PET interpretations in oncologic imaging is FDG uptake in brown fat. The purpose of this study was to determine the prevalence, location, and appearance of hypermetabolic brown fat in the mediastinum.
MATERIALS AND METHODS. All PET/CT scans obtained at our cancer institution from August to October 2003 were retrospectively reviewed for increased FDG uptake in the mediastinum localized to fat on CT. The following features were recorded: location, appearance, maximal standard uptake value (SUVmax) of hypermetabolic mediastinal brown fat, and presence of extramediastinal brown fat.
RESULTS. PET/CT scans were obtained in 845 oncologic patients. Fifteen patients (1.8%) with focal hypermetabolic mediastinal brown fat were identified: nine women and two men (age range, 27–79; mean, 55.1 years) and four children (age range, 5–16 years; mean, 10 years). Hypermetabolic mediastinal brown fat (mean SUVmax, 5.7) was more common in children (4/8) than in adults (11/837) and more common in women (9/372) than in men (2/465). Foci of hypermetabolic brown fat were localized to the paratracheal, paraesophageal, prevascular, and pericardial regions; interatrial septum; and azygoesophageal recess. Five patients had focal hypermetabolic brown fat isolated to the mediastinum. Ten patients also had extramediastinal hypermetabolic brown fat in the neck, thorax, and abdomen. There was no difference in the body weight (p = 0.876) or body mass index (p = 0.538) of patients with hypermetabolic brown fat compared with age- and sex-matched control subjects.
CONCLUSION. Hypermetabolic brown fat can be localized to the mediastinum and manifests as focal increased FDG uptake. Knowledge of this potential pitfall and precise localization with fusion PET/CT are important in preventing misinterpretation as malignancy.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A. B. Goldfine, F. C. Kuo, E. L. Palmer, Y.-H. Tseng, A. Doria, et al. Identification and Importance of Brown Adipose Tissue in Adult Humans N. Engl. J. Med., April 9, 2009; 360(15): 1509 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Farmer Molecular determinants of brown adipocyte formation and function Genes & Dev., May 15, 2008; 22(10): 1269 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Sung, K. S. Lee, B.-T. Kim, S. Kim, O J. Kwon, J. Y. Choi, and S.-O. Yang Nonpalpable Supraclavicular Lymph Nodes in Lung Cancer Patients: Preoperative Characterization with 18F-FDG PET/CT Am. J. Roentgenol., January 1, 2008; 190(1): 246 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yoon, Z. Liang, X. Zhang, M. Choe, A. Zhu, H. T. Cho, D. M. Shin, M. M. Goodman, Z. Chen, and H. Shim CXC Chemokine Receptor-4 Antagonist Blocks Both Growth of Primary Tumor and Metastasis of Head and Neck Cancer in Xenograft Mouse Models Cancer Res., August 1, 2007; 67(15): 7518 - 7524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nedergaard, T. Bengtsson, and B. Cannon Unexpected evidence for active brown adipose tissue in adult humans Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E444 - E452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hadi, C. C. Chen, M. Whatley, K. Pacak, and J. A. Carrasquillo Brown Fat Imaging with 18F-6-Fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma J. Nucl. Med., July 1, 2007; 48(7): 1077 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. EVANS, T. A. TULLOSS, and N. HALL 18FDG Uptake in Brown Fat: Potential for False Positives Radiol. Technol., May 1, 2007; 78(5): 361 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. O'Connor and C. Whittaker Radiologic Findings that Mimic Malignancy Am. J. Roentgenol., October 1, 2006; 187(4): W357 - W364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Bryant, R. J. Cerfolio, K. M. Klemm, and B. Ojha Maximum Standard Uptake Value of Mediastinal Lymph Nodes on Integrated FDG-PET-CT Predicts Pathology in Patients with Non-Small Cell Lung Cancer Ann. Thorac. Surg., August 1, 2006; 82(2): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bunyaviroch and R. E. Coleman PET Evaluation of Lung Cancer J. Nucl. Med., March 1, 2006; 47(3): 451 - 469. [Full Text] [PDF]
|
|
|
|
|
|
Z. Liang, Y. Yoon, J. Votaw, M. M. Goodman, L. Williams, and H. Shim Silencing of CXCR4 Blocks Breast Cancer Metastasis Cancer Res., February 1, 2005; 65(3): 967 - 971. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
